Syros Pharmaceuticals Inc. (SYRS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
ARK Investment Management

Catherine D. Wood

7,711,724 $57,684 -15% 0.11%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

2,189,199 $14,769 2.72%
3.
OrbiMed Advisors

Samuel Isaly

1,837,500 $13,745 +18% 0.12%
4.
EcoR1 Capital

Oleg Nodelman

1,000,000 $7,480 0.33%
5.
RA Capital Management

Peter Kolchinsky

900,000 $6,732 0.1%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.86 10,000 Director 10,000 2020-05-13 Filing
$4.97 10,121 Officer 35,000 2019-11-12 Filing
$4.99 9,879 Officer 24,879 2019-11-11 Filing
$7.50 533,332 Director 1,593,270 2019-04-09 Filing
$9.55 209,424 Director 1,059,938 2018-01-31 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.47 3,628 Officer 0 2021-03-15 Filing
$12.05 3,750 Director 321,711 2021-02-16 Filing
$13.04 3,750 Director 325,461 2021-02-08 Filing
$8.75 5,357 Director 329,211 2020-11-17 Filing
$8.98 633 Director 334,568 2020-11-16 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 584,272 $3,184 0.02%
2. 115,785 $631 0%
3. 100 $1 0%
4. 0 $0 0%
5. 20 $0 0%
News See All